Clinical Trial Update: Evaluation of a CD4/CD8+ Interferon Gamma Release Assay for Monitoring Anti-Tuberculosis Treatment

View source ↗

Summary

This clinical trial evaluates a CD4/CD8+ Interferon Gamma Release Assay for monitoring anti-tuberculosis treatment, in patients with tuberculosis. The study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Snippet

Sponsor: Paola Mantegani | Conditions: Tuberculosis | Status: ACTIVE_NOT_RECRUITING